Optiver Holding B.V. Tg Therapeutics, Inc. Transaction History
Optiver Holding B.V.
- $6 Billion
- Q3 2025
A detailed history of Optiver Holding B.V. transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Optiver Holding B.V. holds 753 shares of TGTX stock, worth $23,425. This represents 0.0% of its overall portfolio holdings.
Number of Shares
753
Previous 21
3485.71%
Holding current value
$23,425
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding TGTX
# of Institutions
399Shares Held
90MCall Options Held
2.28MPut Options Held
1.68M-
Vanguard Group Inc Valley Forge, PA15.5MShares$483 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$354 Million0.0% of portfolio
-
State Street Corp Boston, MA7.62MShares$237 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.44MShares$107 Million0.01% of portfolio
-
Clearbridge Investments, LLC New York, NY3.05MShares$95 Million0.09% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.52B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...